Efficacy of new inotropic drugs in clinical coronary heart failure
- 1 July 1978
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 65 (1) , 197-202
- https://doi.org/10.1016/0002-9343(78)90710-6
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Dobutamine: development of a new catecholamine to selectively increase cardiac contractility.Circulation Research, 1975
- CLINICAL CARDIOVASCULAR PHARMACOLOGY OF DOBUTAMINE A SELECTIVE INOTROPIC CATECHOLAMINEThe Lancet, 1974
- Attempt to quantitate relation between cardiac function and infarct size in acute myocardial infarction.Heart, 1974
- Effect of pharmacologic agents on the function of the ischemic heartThe American Journal of Cardiology, 1973
- Clinical significance of positive inotropic action of digoxin in patients with left ventricular disease.Heart, 1973
- A Hemodynamic Comparison of Dopamine and Isoproterenol in Patients in ShockCirculation, 1969
- Low output syndromeThe Journal of Thoracic and Cardiovascular Surgery, 1969
- Unresolved problems in coronary careThe American Journal of Cardiology, 1967
- Studies in Clinical Shock and Hypotension. II. Hemodynamic Effects of Norepinephrine and Angiotensin*Journal of Clinical Investigation, 1965
- PERIPHERAL VASCULAR EFFECTS OF NORADRENALINE, ISOPROPYLNORADRENALINE AND DOPAMINEBritish Medical Bulletin, 1963